Natalizumab-induced autoimmune hepatitis in a patient with multiple sclerosis.
E H
EH
Martínez-Lapiscina
F
F
Lacruz
F
F
Bolado-Concejo
I
I
Rodríguez-Pérez
T
T
Ayuso
M
M
Garaigorta
J M
JM
Urman
D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D005260:Female; D019693:Hepatitis, Autoimmune / Q000209:etiology* / Q000473:pathology* / Q000503:physiopathology; D006801:Humans; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000503:physiopathology; D000069442:Natalizumab
D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab